ng-nitroarginine methyl ester has been researched along with Peripheral Arterial Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castilla, D; Lassance-Soares, RM; Li, Y; Liu, ZJ; Parikh, PP; Regueiro, M; Shao, H; Vazquez-Padron, R; Velazquez, OC; Webster, KA | 1 |
| Heiss, C; Kelm, M; Nicolaus, C; Sansone, R; Schuler, D | 1 |
| Hodges, GJ; Nawaz, S; Tew, GA | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Peripheral Arterial Disease
| Article | Year |
|---|---|
A Reliable Mouse Model of Hind limb Gangrene.
Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Femoral Artery; Gangrene; Hindlimb; Ischemia; Ligation; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peripheral Arterial Disease; Regional Blood Flow; Species Specificity; Time Factors | 2018 |
Repetitive remote occlusion (RRO) stimulates eNOS-dependent blood flow and collateral expansion in hindlimb ischemia.
Topics: Animals; Benzoates; Blood Flow Velocity; Case-Control Studies; Disease Models, Animal; Enzyme Activators; Femoral Artery; Guanylate Cyclase; Hindlimb; Humans; Ischemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peripheral Arterial Disease; Pilot Projects; Regional Blood Flow; Therapeutic Occlusion | 2018 |
Evidence that reduced nitric oxide signal contributes to cutaneous microvascular dysfunction in peripheral arterial disease.
Topics: Aged; Female; Hemodynamics; Humans; Laser-Doppler Flowmetry; Male; Microvessels; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peripheral Arterial Disease; Skin; Vasodilation | 2015 |